Skip to main content

Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia.

Publication ,  Journal Article
McKee, JA; Brewer, RP; Macy, GE; Phillips-Bute, B; Campbell, KA; Borel, CO; Reynolds, JD; Warner, DS
Published in: Crit Care Med
March 2005

OBJECTIVE: Based on preclinical investigations, magnesium sulfate (MgSO4) has gained interest as a neuroprotective agent. However, the ability of peripherally administered MgSO4 to penetrate the blood-brain barrier is limited in normal brain. The current study measured the passage of intravenously administered Mg into cerebrospinal fluid in patients with brain injury requiring ventricular drainage. DESIGN: A prospective evaluation of the cerebrospinal fluid total and ionized magnesium concentration, [Mg], during sustained hypermagnesemia was performed. SETTING: Neurosciences intensive care unit at a major teaching institution. PATIENTS: Thirty patients with acute brain injury secondary to subarachnoid hemorrhage, traumatic brain injury, primary intracerebral hemorrhage, subdural hematoma, brain tumor, central nervous system infection, or ischemic stroke were studied. INTERVENTIONS: Patients underwent 24 hrs of induced hypermagnesemia during which total and ionized cerebrospinal fluid [Mg] was measured. Serum [Mg] was adjusted to 2.1-2.5 mmol/L. Cerebrospinal fluid [Mg] was measured at baseline, at 12 and 24 hrs after onset of infusion, and at 12 hrs following infusion termination. MEASUREMENTS AND MAIN RESULTS: At baseline, total (1.25 +/- 0.14 mmol/L) and ionized (0.80 +/- 0.10 mmol/L) cerebrospinal fluid [Mg] was greater than serum total (0.92 +/- 0.18 mmol/L) and ionized (0.63 +/- 0.07 mmol/L) [Mg] (p < .05). Total (1.43 +/- 0.13 mmol/L) and ionized (0.89 +/- 0.12 mmol/L) cerebrospinal fluid [Mg] was maximally increased by 15% and 11% relative to baseline, respectively, during induced hypermagnesemia (p < .05). CONCLUSIONS: Hypermagnesemia produced only marginal increases in total and ionized cerebrospinal fluid [Mg]. Regulation of cerebrospinal fluid [Mg] is largely maintained following acute brain injury and limits the brain bioavailability of MgSO4.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Crit Care Med

DOI

ISSN

0090-3493

Publication Date

March 2005

Volume

33

Issue

3

Start / End Page

661 / 666

Location

United States

Related Subject Headings

  • Neuroprotective Agents
  • Middle Aged
  • Male
  • Magnesium Sulfate
  • Magnesium
  • Infusions, Intravenous
  • Humans
  • Female
  • Emergency & Critical Care Medicine
  • Brain Injuries
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McKee, J. A., Brewer, R. P., Macy, G. E., Phillips-Bute, B., Campbell, K. A., Borel, C. O., … Warner, D. S. (2005). Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med, 33(3), 661–666. https://doi.org/10.1097/01.ccm.0000156293.35868.b2
McKee, J Andrew, Randall P. Brewer, Gary E. Macy, Barbara Phillips-Bute, Kurt A. Campbell, Cecil O. Borel, James D. Reynolds, and David S. Warner. “Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia.Crit Care Med 33, no. 3 (March 2005): 661–66. https://doi.org/10.1097/01.ccm.0000156293.35868.b2.
McKee JA, Brewer RP, Macy GE, Phillips-Bute B, Campbell KA, Borel CO, et al. Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med. 2005 Mar;33(3):661–6.
McKee, J. Andrew, et al. “Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia.Crit Care Med, vol. 33, no. 3, Mar. 2005, pp. 661–66. Pubmed, doi:10.1097/01.ccm.0000156293.35868.b2.
McKee JA, Brewer RP, Macy GE, Phillips-Bute B, Campbell KA, Borel CO, Reynolds JD, Warner DS. Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med. 2005 Mar;33(3):661–666.

Published In

Crit Care Med

DOI

ISSN

0090-3493

Publication Date

March 2005

Volume

33

Issue

3

Start / End Page

661 / 666

Location

United States

Related Subject Headings

  • Neuroprotective Agents
  • Middle Aged
  • Male
  • Magnesium Sulfate
  • Magnesium
  • Infusions, Intravenous
  • Humans
  • Female
  • Emergency & Critical Care Medicine
  • Brain Injuries